Cohort study on pancreatic diseases in Toulouse
PAncreatic Disease Cohort of TOuLouse
University Hospital, Toulouse · NCT05824403
This study is trying to find better ways to diagnose and manage different pancreatic diseases, like pancreatitis and cysts, by collecting health information and samples from patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Toulouse (other) |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT05824403 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with various pancreatic diseases, excluding cancer, to develop diagnostic tools for differentiating between benign, potentially malignant, and malignant conditions. It involves the collection of clinical data and biological samples to enhance understanding and management of pancreatic pathologies. The study aims to improve monitoring and diagnostic performance for conditions such as acute and chronic pancreatitis and pancreatic cysts.
Who should consider this trial
Good fit: Ideal candidates include patients with inflammatory or cystic exocrine pancreatic pathologies who can provide informed consent.
Not a fit: Patients with pancreatic cancer or other active cancers, as well as pregnant or breastfeeding individuals, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better diagnostic tools and management strategies for patients with pancreatic diseases.
How similar studies have performed: While similar studies have explored pancreatic diseases, this specific cohort approach focusing on non-cancerous conditions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with inflammatory or cystic exocrine pancreatic pathology * Patient able to read and understand the information leaflet * Patients who have agreed to participate in the study and have signed the free and informed consent * Patients affiliated to a social security system (including AME) Exclusion Criteria: * Patient with pancreatic cancer pathology * Patients with active cancer, whatever the origin * Pregnant or breastfeeding patients * Patients under legal protection, guardianship or trusteeship
Where this trial is running
Toulouse
- Rangueil hospital — Toulouse, France (RECRUITING)
Study contacts
- Principal investigator: Barbara BOURNET, MD — University Hospital, Toulouse
- Study coordinator: Barbara BOURNET, MD
- Email: bournet.b@chu-toulouse.fr
- Phone: 0561323235
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pancreatic Diseases, Pancreatic cyst, Acute pancreatitis, chronic pancreatitis, Intra Pancreatic Mucinous Neoplasia, diagnosis